Role of Pseudomonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes, and monocytes)

Infection and Immunity

Volumn 64, Issue 8, 1996, Pages 3252-3258

  Konig B ^a   Jaeger, K E ^a   Sage, A E ^b   Vasil, M L ^b   Konig W ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; BETA GLUCURONIDASE; CALCIMYCIN; HISTAMINE; INTERLEUKIN 8; LEUKOTRIENE B4; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE C; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL LIPASE;

ARTICLE; BASOPHIL; CHEMOLUMINESCENCE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; EFFECTOR CELL; GRANULOCYTE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MEDIATOR RELEASE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; THROMBOCYTE;

EID: 0030017108     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.8.3252-3258.1996     Document Type: Article

References (53)

1. Baggiolini, M., and I. Clark-Lewis. 1992. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 307:97-101.
2. Baltimore, R. S., C. D. Christie, and G. J. Smith. 1989. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am. Rev. Respir. Dis. 140:1650-1661.
3. Bazzoni, F., M. A. Cassatella, F. Rossi, M. Ceska, B. Dewald, and M. Baggiolini. 1991. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J. Exp. Med. 173:771-773.
4. Bergmann, U., J. Scheffer, M. Köller, W. Schönfeld, G. Erbs, F. E. Müller, and W. König. 1989. Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect. Immun. 57:2187-2195.
5. Berka, R. M., G. L. Gray, and M. L. Vasil. 1981. Studies on phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa. Infect. Immun. 34:1071-1074.
6. Berka, R. M., and M. L. Vasil. 1982. Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization. J. Bacteriol. 52:239-245.
7. Bigby, T. D., and N. Meslier. 1989. Transcellular lipoxygenase metabolism between monocytes and platelets. J. Immunol. 143:1948-1954.
8. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes by one step centrifugation and sedimentation at 1g. Scand. J. Clin. Lab. Invest. 21:77-79.
9. Brunschwig, E., and A. Darzins. 1992. A two-component T7 system for the overexpression of genes in Pseudomonas aeruginosa. Gene 111:35-41.
10. Chin, J. C., and J. E. Watts. 1988. Biological properties of phospholipase C purified from a fleecerot isolate of Pseudomonas aeruginosa. J. Gen. Microbiol. 134:2567-2575.
11. Church, J. A., T. G. Keers, and C. Wang. 1980. Neutrophil and monocyte chemotaxis in acutely infected patients with cystic fibrosis. Ann. Allergy 45:217-221.
12. Colditz, I. G., R. D. Zwahlen, and M. Baggiolini. 1990. Neutrophil accumulation and plasma leakage induced in vivo by neutrophil-activating peptide-1. J. Leukocyte Biol. 48:129-137.
13. Coutinho, I. R., R. S. Berk, and E. Mammen. 1988. Platelet aggregation by phospholipase C from Pseudomonas aeruginosa. Thromb. Res. 51:495-505.
14. Döring, G. 1993. Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients, p. 245-273. In M. Campa, M. Bendinelli, and H. Friedman (ed.), Pseudomonas aeruginosa as an opportunistic pathogen. Plenum Press, New York.
15. Pick, R. B., T. J. Standigford, S. L. Kunkel, and R. M. Strieter. 1992. Interleukin-8 mediated neutrophil accumulation in the inflammatory airways disease of cystic fibrosis. Am. Rev. Respir. Dis. 124:221-225.
16. Ford-Hutchinson, A. W., M. Gresser, and R. N. Young. 1994. 5-Lipoxygenase. Annu. Rev. Biochem. 63:383-417.
17. Friedl, P., B. König, and W. König. 1992. Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells. Immunology 76:86-94.
18. Goetzl, J., M. Woods, and R. R. Gorman. 1977. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. J. Clin. Invest. 59:179-183.
19. Hancock, R. E. W., K. Pode, and R. Benz. 1982. Outer membrane protein P of Pseudomonas aeruginosa: regulation by phosphate deficiency and formation of small anion-specific channels in lipid bilayer membrane. J. Bacteriol. 150:730-738.
20. Høiby, N. 1991. Cystic fibrosis infection. Schweiz. Med. Wochenschr. 121:105-111.
21. 20a.Jaeger, K.-E. Personal communication.
22. Jaeger, K.-E., A. Kharazmi, and N. Hoiby. 1991. Extracellular lipase of Pseudomonas aeruginosa: biochemical characterization and effects on human neutrophil and monocyte function in vitro. Microb. Pathog. 50:121-126.
23. Jaeger, K.-E., D. A. Kinscher, B. König, and W. König. 1992. Extracellular lipase of Pseudomonas aeruginosa: biochemistry and potential role as a virulence factor, p. 113-119. In N. Hoiby and S. S. Pedersen (ed.), Cystic fibrosis, basic and clinical research. Elsevier Science Publishers BV, Amsterdam.
24. Kindt, G. C., H. J. E. Gadetz, and J. E. Weiland. 1991. Initial recruitment of neutrophils to alveolar structures in acute lung injury. J. Appl. Physiol. 70:1575-1585.
25. Knöller, J., W. Schönfeld, M. Köller, T. Hensler, and W. König. 1988. Arachidonic acid metabolites from polymorphonuclear leukocytes of healthy donors, severely burned patients, and children with cystic fibrosis. Routine monitoring by high performance liquid chromatography. J. Chromatogr. 427:199-208.
26. König, B., A. Anastassiadou, B. Tümmler, and W. König. Interaction of Pseudomonas aeruginosa with human phagocytes is infection phase specific in cystic fibrosis. Submitted for publication.
27. König, B., U. Bergmann, and W. König. 1992. Induction of inflammatory mediator release (serotonin and 12-hydroxyeicosatetraenoic acid) from human platelets by Pseudomonas aeruginosa glycolipid. Infect. Immun. 60:3150-3155.
28. König, B., P. Friedl, S. S. Pedersen, and W. König. 1992. Alginate - its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria. Int. Arch. Allergy Immunol. 99:98-106.
29. König, B., K.-E. Jaeger, and W. König. 1994. Induction of inflammatory mediator release (12-hydroxyeicosatetraenoic acid) from human platelets by Pseudomonas aeruginosa. Int. Arch. Allergy Immunol. 104:33-41.
30. König, B., and W. König. 1993. Induction and suppression of cytokine release (TNF-alpha; IL-6; IL-1β) by E. coli pathogenicity factors (adhesins, alpha-hemolysin). Immunology 78:526-533.
31. König, B., W. Schönfeld, J. Scheffer, and W. König. 1990. Signal transduction in human platelets and inflammatory mediator release induced by genetically cloned hemolysin-positive and -negative Escherichia coli strains. Infect. Immun. 58:1591-1599.
32. König, W., W. Schönfeld, M. Raulf, M. Köller, J. Kn̈ller, J. Scheffer, and J. Brom. 1990. The neutrophil and leukotrienes - role in health and disease. Eicosanoids 3:1-20.
33. Konstan, M. W., R. W. Walenga, K. A. Hiliard, and M. Berger. 1991. Eicosanoid content of bronchoalveolar lavage fluid is markedly elevated in cystic fibrosis. Pediatr. Pulm. 6:302-309.
34. Kurioka, S., and P. V. Liu. 1967. Effect of Pseudomonas aeruginosa on phosphatides and on phospholipase C activity. J. Bacteriol. 93:670-674.
35. Liu, P. V. 1979. Toxins of Pseudomonas aeruginosa, p. 63-89. In R. G. Dogget (ed.), Pseudomonas aeroginosa: clinical manifestation of infection and current therapy. Academic Press, Inc., New York.
36. Marom, Z., J. H. Shelhamer, and M. Kaliner. 1981. Effects of arachidonic acid monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airway in vitro. J. Clin. Invest. 67:1695-1702.
37. Meyers, D. J., and R. S. Berk. 1990. Characterization of phopsholipase C from Pseudomonas aeruginosa as a potent inflammatory agent. Infect. Immun. 58:659-666.
38. Moreau, H., C. Jolivet-Reynaud, and J. E. Alouf. 1988. Enzymatic and cytolytic mechanism of Clostridium perfringens alpha toxin, p. 65-66. In P. Falmagne, J. E. Alouf, F. J. Fehrenbach, J. Jeljaszewicz, and M. Thelestam (ed.), Bacterial protein toxins. Gustav Fischer Verlag, Weinheim, Germany.
39. Nathan, P., I. A. Holder, and B. G. MacMillan. 1983. Burn wounds: microbiology, local host defenses and current therapy. Crit. Rev. Clin. Lab. Sci. 4:61-65.
40. Nicas, T. I., and B. Iglewski. 1986. Toxins and virulence factors of Pseudomonas aeruginosa, p. 195-213. In J. R. Sokatch (ed.), The biology of Pseudomonas. Academic Press, Inc., Orlando, Fla.
41. Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature (London) 308:693-698.
42. Ostroff, R. M., B. Wretlind, and M. L. Vasil. 1989. Mutations in the hemolytic-phospholipase C operon result in decreased virulence of Pseudomonas aeruginosa PAO1 grown under phosphate-limiting conditions. Infect. Immun. 57:1369-1373.
43. Ostroff, R. M., A. I. Vasil, and M. L. Vasil. 1990. Molecular comparison of a nonhemolytic and a hemolytic phospholipase C from Pseudomonas aeruginosa. J. Bacteriol. 172:5915-5923.
44. Scheffer, J., W. König, V. Braun, and W. Goebel. 1988. Comparison of four hemolysin-producing organisms (Escherichia coli, Serratia marcescens, Aeromonas hydrophila, and Listaria monocytogenes) for release of inflammatory meditors from various cells. J. Clin. Microbiol. 26:544-551.
45. Schönfeld, W., A. Saak, G. Steinkamp, H. van der Hardt, and W. König. 1989. Histamine release from basophils in cystic fibrosis. Clin. Exp. Immunol. 76:434-439.
46. Shortridge, V. D., A. Lazdunski, and M. L. Vasil. 1992. Osmoprotectants and phosphate regulate expression of phospholipase C in Pseudomonas aeruginosa. Mol. Microbiol. 6:863-871.
47. Sorenson, R. U., and F. Joseph, Jr. 1993. Phenazine pigments in Pseudomonas aeruginosa infection, p. 43-54. In M. Campa, M. Bendinelli, and H. Friedman (ed.), Pseudomonas aeruginosa as an opportunistic pathogen. Plenum Press, New York.
48. Spector, A. A., J. A. Gordon, and S. A. Moore. 1988. Hydroxyeicosatetraenoic acids (HETES). Prog. Lipid Res. 27:271-323.
49. Stenson, W. F., and C. W. Parker. 198o. Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils. J. Immunol. 124:2100-2104.
50. Titball, R. W., D. L. Leslie, S. Harvey, and D. Kelly. 1991. Hemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway. Infect. Immun. 59:1872-1874.
51. Tucker, S. B., R. V. Pierre, and R. E. Jordon. 1977. Rapid identification of monocytes in a mixed mononuclear cell preparation. J. Immunol. Methods 14:267-269.
52. Vasil, M. L., M. Graham, R. M. Ostroff, V. D. Shortridge, and A. I. Vasil. 1991. Phospholipase C: molecular biology and contribution to the pathogenesis of Pseudomonas aeruginosa. Antibiot. Chemother. (Basel) 44:34-47.
53. Willems, J., M. Joniau, S. Cinque, and J. van Damme. 1991. Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other cytokines. Immunology 67:540-542.